Stay updated with breaking news from Contingent value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Revenue up 211% from Q3 2022Gross profit up 401% from Q3 2022Operating Expenses up 125% from Q3 2022Net Loss from continuing operations decreased 8% from Q3 2022Pro forma adjusted EBITDA up 156% from Q3 2022Positive cash ....
Orchard Therapeutics (NASDAQ: ORTX) experienced a remarkable 97% surge in its shares following a major announcement on October 5th, 2023. The renowned global gene therapy leader, Orchard, has been successfully acquired by Kyowa Kirin (OTC: KYKOF), solidifying its position as a fully owned subsidiary. The Agreement: The agreement outlines that Kyowa plans to buy all ....